Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III observer-blind study of GSK2186877A influenza vaccine versus Fluarix in prior study 111737 participants
2009-012188-32Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-blind trial of GSK2186877A and Fluarix in influenza (3 arms), sponsored by GSK. Primary endpoints: Solicited local symptoms and Solicited general symptoms. Started Jul 2009; status: completed.
02
Drugs
GSK2186877AFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-012188-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012188-32.